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REVIEW
Abstract: Global growth of the elderly population is requiring healthcare providers to cater
for an expanding elderly cancer subpopulation. The aggression with which cancer should be
treated in this subpopulation is an ethical dilemma and is an ongoing debate, as surgeons have
feared increases in postoperative morbidity and mortality. As a result elderly patients often
receive suboptimal cancer treatment. The need for standardization of cancer surgery is well
recognized despite the difficulties in view of heterogeneity of the group. In this article,
epidemiological changes, tumor biology specific to elderly cancer are visited, operative risk
assessment tools are discussed, and interim results of ongoing multinational investigation ie,
PACE (Preoperative Assessment of Cancer Elderly) revealed.
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Introduction
The definition of “elderly” is controversial. The traditional demographic definitions
include those patients exceeding 65 years of age. Census statistics show that this age
group is expected to rise. Agreement on what constitutes the elderly cancer patient is
particularly vital since the community age structure is very dynamic (Taueber 1993).
Functional deterioration is more frequently apparent beyond the age of 70 years
(Yancik et al 1998). No two elderly individuals are same: they differ in their physical
fitness, cognitive level, and presence of co-morbidities, quality of life, and life
expectations. Surprisingly, few objective instruments have been made available to
categorise age-related pre-existing chronic illness; age related functional physical
decline, or preoperative risk status (Copeland et al 1991; Yancik et al 1998; Ogle et
al 2000).
Ageism is defined as a “prejudice towards, stereotyping of and/or discrimination
against any person or persons directly and solely as a function of their having attained
a chronological age which the social group defines as old” (APA 2005). Ageism
attitudes are deep-rooted in mankind and are reflected in language, attitude, beliefs,
behaviours, and policies (Penson et al 2004). Healthcare providers, including surgeons,
are no exception to ageist bias. Age frequently affects the overall cancer treatment
plan, including the surgeon’s view towards operative strategy and multi-modal
treatment (Ogle et al 2000). The majority of surgical oncologists seem to be aware of
the burden of elderly patients affected by cancer and are not biased by an ageist
approach. However there is disturbing evidence of a wide variety of treatment options
offered, ranging from a minimalist approach to over-treatment (Audisio, Osman, et
al 2004).
Cancer is a disease of the aging. Solid tumors predominantly affect the aged and
most cancer-related deaths occur within this age group (Brookes 1937; Wallach and
Kurtz 1990; Alexander et al 1991). The elderly receive substandard cancer treatment
in comparison with the young although the quoted reasons are many (Welch 1948;
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Greenfield 1975; Boyd et al 1980; Greenburgh et al 1985;
Samet et al 1986; Brow et al 1991; Fallahzadeh and Mays
1991; Firat, Bousamra, et al 2002; Audisio, Bozzetti, et al
2004). This has prompted several surgical oncologists to
review their series. Outcomes of these are superimposable
long-term cancer-related outcome across all age groups and
short term complications and mortality which do not seem
to differ in a highly selected patient group undergoing cancer
surgery (Vercelli et al 1998; Firat, Byhardt, et al 2002).
Surgery for elderly cardiac, orthopaedic, and vascular
diseases is increasingly accepted. Yet, the reluctance to offer
optimal cancer surgery continues (Alexander et al 1991)
although it remains the primary treatment for solid cancer
(Wallach and Kurtz 1990). Our limited knowledge of the
elderly sub-population is due to the exclusion of onco-
geriatric patients from clinical trials (Brow et al 1991;
Fallahzadeh and Mays 1991; Firat, Bousamra, et al 2002).
There is an urgent need for expanding our understanding of
cancer behavior and cancer management for this unique
group. Better understanding will come with elderly patients
taking part in clinical research and by encouraging clinicians
to take part in scientific meetings dedicated to onco-
geriatrics.
Epidemiology
The median life expectancy of population among
industrialized countries has dramatically expanded in recent
years. An effect of an absolute rise in geriatric population
among populous countries (ie, China, India, and Brazil)
despite smaller in proportion (11% to 15%), and a higher
proportionate rise (20%) in developed countries by 2020,
is likely to lead to geriatric population explosion (Day 1996;
US Census 1996; Kalache and Keller 2000). At the end of
the 19th century, the average life expectancy was 40 years,
but has now doubled to 81 years of expected survival for
females, and 76 years for males in the UK. A 60 year old
subject is now expected to survive for 24 years and an 80
year old is expected to survive for 6 years in Western Europe
(Lag et al 1999). On the other hand, the risk of developing
cancer increases with age. According to the Cancer
Incidence, Mortality and Prevalence in the European Union
(EUCAN) 90 data, 58% of cancers, and 69% of cancer
deaths, affect subjects aged 65 years or more. When all
tumors are taken into account, the risk of developing cancer
among persons older than 65 is 2.9-fold for males and 2.2-
fold for females, in comparison with 55 to 64 year olds
(Coeburgh 2001). According to the SEER (Surveillance
Epidemiology and End Results) data, the prevalence of
cancer is 207.4 cases/100 000 in the <65 year old subjects,
and 2163.9/100 000 in >65 year old subjects in the US.
Mortality in this survey was 68.8 and 1076.2/100 000
subjects, respectively. This means cancer prevalence is 10
times, and mortality 15 times higher in the >65 year olds
(Lag et al 1999).
Le Quintree et al (2005) concluded the methodological
quality of randomized controlled trials (RCT) in very elderly
subjects is equivalent to that of RCT in the general adult
population. Nevertheless, RCT are very scarce and neglect
certain diseases. RCT in elderly should be strongly
encouraged (Le Quintree et al 2005). Since only a small
sub-setting of geriatric patients are being entered into clinical
trials (De Rijke et al 1996, 2000, 2002; Barchielli and Balzi
2000), elderly patients are still being managed on the
assumptions and outcomes derived from a younger cancer
patient.
Despite this epidemiological “time bomb” (Masoro
1997; Redmond and Aapro 1997), there is concern that the
scientific community has so far been unable to develop a
significant amount of evidence-based knowledge.
Tumor biology
The increase in incidence of cancer with age is related to a
number of biologic factors. Age-related etiological factors
includes decreased immune surveillance, longer duration
of carcinogenic exposure, increased susceptibility of cells
to carcinogens, decreased DNA repair, oncogene activation
or amplification, and defects in tumor-suppressor genes. The
biological behaviour of neoplasm, once initiated, may vary
in different age groups depending on tumour type, immune
system status, and alterations in other regulatory factors such
as angiogenesis. Attention to age-related biological changes
are essential to the designing of successful therapy (Cohen
1994).
The biology of cancers differs in various age groups,
with variations in growth patterns, and doubling times,
intrinsic hormonal receptor expression, DNA ploidy, tumor
angiogenesis, percentage of cells in S-phase, p53 expression,
and extracellular matrix protein expression (Piantanelli
1988; Cutler and Sensei 1989; Cristofalo et al 1994;
Osiewicz and Hamann 1997). The microenvironment of
senescent tissue is less capable of supporting rapid tumor
growth. Histologically identical tumor in older patients may
behave differently (Olshansky et al 1990; Holmes et al 1991;
Eppenberger-Castori et al 2002; Anisimov 2003). TheClinical Interventions in Aging 2006:1(3) 223
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subcellular changes involved in the aging process and the
effect of particular aging ‘phenotype’ has on cancer
susceptibility is ill-understood (Thigpen 1998; Ling et al
2000). The correlation between immune system and cancer
development/progression are currently poorly understood
(Ling et al 2000; Schindowski et al 2002; Zhang et al 2002).
Prolonged tumor-associated antigen exposure associated
with immune ‘exhaustion’ and absence of repair genes is
the predominance of a ‘frail’ gene variant (Baramiya 2000;
Franceschi et al 2000; Ling et al 2000).
Age influences the predilection of cancer for disease site
and histology type, ie, higher incidence of adeno-carcinoma
of the distal esophagus, well-differentiated gastric tumors,
right-sided colonic cancer, and low-grade lobular or
mucinous type breast tumors in the elderly population have
been reported (Audisio, Veronesi, et al 1997). Similarly a
higher incidence of larger thyroidal tumour with Hürthle
cell variant, extra-thyroidal growth and metastases at
presentation are noted in elderly (Audisio and Zbar 2002).
Elderly patients have greater frequency of tumors with more
indolent histology and an overall favorable tumor profile
(Hayman and Muss 2003): Older women with breast cancer
tend to have more estrogen receptor-positive tumors (Wyld
and Reed 2003). These basic pathological differences will
inherently affect outcome (Franceschi et al 2000). For most
types of solid epithelial tumors, old age itself does not appear
to function as an independently negative prognostic variable
for cancer-specific survival; a finding evident in recent
studies assessing colorectal cancer (Audisio, Cazzaniga, et
al 1997; Staudacher et al 2000; Chiappa et al 2001), gastric
cancer (Lo et al 1996; Kitamura et al 1999), esophageal
carcinoma (Jougon et al 1997; Poon et al 1998), liver
(Chiappa et al 1999), head & neck (Robinson 1994; Rapidis
et al 1998) and breast cancers (Veronesi et al 1988; Desch
et al 1993; Newschaffer et al 1996; Siliman 1996).
More complex issues, however, impact on different age
groups and affect their overall and disease-free survival.
Surgical risk assessment
The most important responsibility a surgeon is asked to take
is to decide whether to operate or not (Jones and de Cossart
1999; de Cossart 2001). This is particularly true when the
patient is a high surgical risk.
The decision-making process is complex in a poor
surgical candidate or frail and elderly: on one side, a nihilistic
approach has been repeatedly reported, which results in
intolerably poor cancer management and outcomes; on the
other, the surgical oncologist must balance the operative
risk against benefits.
A number of factors, including a greater need for
information, a more effective utilization of available
resources, and advances in peri-operative management and
surgical techniques, demand an improved risk definition to
be shared between the surgeon and the patient.
Unfortunately there seems to be no laboratory test
capable of predicting postoperative adverse outcomes
(Balducci et al 2001).
None of the risk classifications aimed at predicting
outcomes in specific conditions used by surgeons are
completely reliable. More importantly, no scoring method
has ever been attempted specifically in the elderly population
and a “CGA-snap-shot” of senior patients undergoing
surgery has never been attempted.
The recommendations of the consensus meeting held
during the 6th International Conference on Geriatric
Oncology (Balducci et al 2001) was that any elderly cancer
patient should firstly be assessed on his/her frailty, and then
considered for appropriate cancer management. We
consecutively endeavor on holistic assessment of this cancer
sub-setting.
Currently available risk assessment tools include
American Society of Anesthesiologists (ASA) scoring
system. The ASA scoring system does not measure operative
risk, rather it globally assess the degree of sickness or
physical state prior to anesthesia and surgery.
Sensitivity of ASA scoring to differentiate the proportion
of patients belonging to ASA II vs III (Leung and Dzankic
2001), where both groups show a similar mortality under
elective conditions (15%) is poor.
The assessment of cardiac risk is addressed by the
Goldman Cardiac Risk Index (CRI) (Goldman et al 1977);
an instrument designed to assess cardiac risk in noncardiac
surgery but is rarely used by surgeons (Michaels et al 1996).
Respiratory complications were analyzed by Kroenke and
colleagues (1993) who identified the following as associated
with postoperative respiratory complications: 1) age over
70; 2) peri-operative broncho-dilator use; 3) abnormal chest
x-ray; and 4) high ASA grade. Lawrence et al (1994)
identified four preoperative variables that were associated
with postoperative respiratory complications: 1) abnormal
respiratory examination; 2) abnormal chest x-ray; 3)
Goldman CRI; and 4) the Charlson co-morbidity index
(Charlson et al 1987). These have not been formalized as a
score or validated.Clinical Interventions in Aging 2006:1(3) 224
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The Acute Physiological and Chronic Health Evaluation
(APACHE) is the best known physiological scoring system
(Knaus et al 1981). It is based on 34 physiological variables
taking the worst values in the first 24 hours from the patient’s
admission to an intensive care unit (ICU). Various
modifications of this APACHE system are now available:
APACHE II (Knaus et al 1985) uses 12 physiological
variables; it is currently being used in general and surgical
intensive care patients. Its application in the ICU seems very
appropriate, but its utility to general surgical patients who
may not require respiratory support in the ICU is limited.
A relatively popular risk assessment tool especially in
UK is POSSUM (Physiological and Operative Severity
Score for EnUmaration of Mortality and Morbidity) as well
as Portsmouth modification (P-POSSUM) (Prytherch et al
1998). The weakness of the tool is to overestimate mortality
rate for low risk procedures, inability to predict
postoperative outcome in preoperative setting and is affected
by surgeon dependent factors rather than intrinsic difficulty
of the case (Bann and Sarin 2001; Sutton et al 2002). Age is
an independent risk factor built into above mentioned risk
prediction tools.
Preoperative Assessment of
Cancer in Elderly (PACE)
PACE is a prospective multicenter, international cooperative
investigation which aims at defining the general health
condition of onco-geriatric surgical candidates. PACE is
designed to assess the functional activities of geriatric patient
and hence to assess the functional life of an onco-geriatric
patient. We propose this will help in predicting the
individualized risk of cancer surgery. The pilot study has
proven PACE is feasible, inexpensive and well accepted by
the patient (Warner 1998). Our study population constituted
of >70 years age patients undergoing moderate, major and
major + elective cancer surgery whose Mini Mental Score
is >18 (ability to give written informed consent). The end
points of the study are 30 days morbidity, 30 days mortality,
and hospital bed days. The aim is to predict preoperatively
the probable outcome of cancer surgery treatment in elderly.
The tools incorporated in the PACE are detailed in Table 1.
Results
213 patients were prospectively recruited for the study from
July 2003 to September 2004. The postoperative outcome
is assessed using a morbidity checklist (Table 2). The interim
analysis results (Table 3) show median age was 76 years
(70–100 years). Postoperative complications were noted in
64 (30%). The median number of co-morbidity was 2 in
Table 1 Validated instruments used with PACE
Mini Mental State Examination (MMS)
Satariano’s Modified Index of Comorbidities
Activities of Daily Living (ADL)
Instrumental Activities of Daily Living (IADL)
Geriatric Depression Scale (GDS)
Brief Fatigue Inventory (BFI)
Eastern Co-operative Oncology Group Performance Status (PS)
American Society of Anesthesiologists Physical Status (ASA)
Physiological and Operative Severity Score for EnUmeration of
Mortality and Morbidity (POSSUM)
Portsmouth POSSUM Modification (P-POSSUM)
Abbreviations: PACE, Preoperative Assessment of Cancer in Elderly.
Table 2 30 days morbidity check
Complications Absent Minor Major
Respiratory
Cardiac failure
Renal failure
Generalized sepsis
Stroke/Neurological problems
Hemorrhage and bleeding
Nutritional problems
Other organ failure
Wound infection/dehiscence
Thromboembolic problems
Hepatic failure
Urinary retention
Anastomotic failure
Peripheral ischemia
Endocrine failure
Pressure sores
Analgesic problems
Others
Table 3 PACE Interim analysis: association of PACE with
postoperative morbidity
Components Complications No p
(64 patients) Complications
(149 patients)
Median (IQR)
Comorbidities 2 (0–3) 1 (0–2) 0.024
MMS 28 (27–30) 28 (26–30) 0.917
GDS 3 (1–6) 2 (1–4) 0.018
BFI 2.2 (0.2–4.4) 1.2 (0–4.4) 0.156
Number of patients (%)
PS = 0 30 (46.9) 122 (81.9) <0.0001
ADL (Dependent) 38 (59.4) 55 (36.9) 0.005
IADL (Independent) 38 (59.4) 114(76.5) 0.043
ASA = 1 or 2 29 (45.1) 72 (49.0) 0.449
Abbreviations: ADL, activities of daily living; ASA, American Society of
Anesthesiologists scoring system; BFI, Brief Fatigue Inventory ; GDS, Geriatric
Depression Scale; IADL, independent activities of daily living; IQR, interquartile;
MMS, Mini Mental State; PS, performance status.Clinical Interventions in Aging 2006:1(3) 225
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complications group and 1 in complications-free group.
Functional assessment using performance status (PS),
(p<0.0001) and activities of daily living (ADL) (p<0.005)
achieved statistical significance in predicting postoperative
morbidity. Aspects of PACE relating to psychological well
being (Geriatric Depression Score, Mini Mental State) do
not appear to be significantly associated with post operative
morbidity. The number of co-morbidities, ASA, instrumental
activities of daily living (IADL) which failed to achieve
statistical significance will be a reassessed on a larger
sample. Recruitment to the study is currently ongoing and
full results will be revealed on completion.
How to improve our
understanding of elderly cancer
patients?
It is estimated that up to a third of cancer deaths is
preventable by the promotion of education. An emphasis
should be on the dangers of a delayed diagnosis, as well as
the erroneous interpretation of misleading symptoms in the
presence of co-morbidities (Audisio et al 2003). Educational
endeavours for elderly should target specialists and general
practitioners alike. Optimizing management of cancer in
elderly requires better understanding. This could be achieved
by encouraging elderly to take part into clinical trials
specifically developed for onco-geriatric series. Elderly
cancer patients should be encouraged to enroll with the same
vigor as their younger counterpart. Elderly wish to
participate in trials in contrast to present perceptions
(Silliman et al 1993). It is also desirable to make cancer
management decision within a dedicated multidisciplinary
(MDT) meeting, comprising of onco-surgeon, oncologist,
radiation therapist, geriatricians, anesthesiologists with
interest in geriatric surgery, and other support staff involved
in elderly patient care. Educational opportunities like
International Society of Geriatrics Oncology (SIOG 2006)
conferences and the European School of Oncology (ESO
2004) courses should be utilized to enhance our knowledge
and to discuss issues pertaining to management of elderly
cancer. Further learning modules should be included in the
medical curriculum in order to learn to look beyond age.
Conclusions
An increase in elderly surgical cancer workload is inevitable
in the coming years. The special needs of elderly cancer
patient should be taken into consideration prior to treatment
planning. Provision of care should honor patients’
preferences across all age groups. More progress in
optimization of surgery for cancer in elderly could be
achieved with the availability of validated tools capable of
predicting postoperative outcomes. Clinical trials should be
specifically developed for onco-geriatric series and elderly
cancer patients should be encouraged to enroll. A
multidisciplinary approach is the way forward. Educational
opportunities like SIOG and ESO should be utilized to
enhance our understanding of this unique subgroup.
Learning modules should be created to look beyond age in
cancer treatment planning. Developments in the surgery and
expansion of our elderly cancer knowledge base are the way
forward to optimize cancer surgery for elderly.
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